Oral candidiasis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Category) |
m (Bot: Removing from Primary care) |
||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 23:00, 29 July 2020
|
Oral candidiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oral candidiasis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Oral candidiasis secondary prevention |
|
Risk calculators and risk factors for Oral candidiasis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Overview
Candida is usually a self limiting disease unless concurrent immunosuppression is present.
Secondary prevention
- Proper treatment of candididiasis using topical agents is usually enough for controlling symptoms.
- In immunocompromised patients, prophylactic fluconazole is effective in reducing recurrences.[1]
References
- ↑ Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE; et al. (2009). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clin Infect Dis. 48 (5): 503–35. doi:10.1086/596757. PMID 19191635.